GLAUCOMA, OPEN-ANGLE
Clinical trials for GLAUCOMA, OPEN-ANGLE explained in plain language.
Never miss a new study
Get alerted when new GLAUCOMA, OPEN-ANGLE trials appear
Sign up with your email to follow new studies for GLAUCOMA, OPEN-ANGLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye drop combo study for glaucoma halted early
Disease control TerminatedThis study tested two different combinations of eye drops to lower eye pressure in people with open-angle glaucoma or ocular hypertension. The goal was to see which combination worked better over 90 days. The study was stopped early and included 28 participants.
Matched conditions: GLAUCOMA, OPEN-ANGLE
Phase: PHASE4 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Glaucoma device showdown ends early: only 10 patients enrolled
Disease control TerminatedThis study aimed to compare two surgical devices—the OMNI system and the iStent inject—for lowering eye pressure in people with open-angle glaucoma who already had cataract surgery. The trial was terminated early and only enrolled 10 participants, so results are limited. Both dev…
Matched conditions: GLAUCOMA, OPEN-ANGLE
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Glaucoma implant trial halted early – what we know
Disease control TerminatedThis study tested a new medical device called Supraflow v1.3, which is implanted in the eye to help drain fluid and lower pressure in people with open-angle glaucoma. The trial included 22 patients whose eye pressure was not controlled with medication. However, the study was term…
Matched conditions: GLAUCOMA, OPEN-ANGLE
Phase: NA • Sponsor: Ciliatech • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC